Vaxart Inc.

NASDAQ: VXRT · Real-Time Price · USD
0.49
-0.04 (-7.98%)
At close: Jun 27, 2025, 3:59 PM

Vaxart Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20.88M 15.19M 4.93M 6.4M 2.18M 3.25M 446K 1.36M 278K 22K n/a n/a 85K 74K 200K 112K 506K
Cost of Revenue
n/a n/a n/a n/a n/a 1.2M 1.2M 1.13M n/a 967K 827K 784K 18.2M 15.53M 12.41M 10.74M 10.07M
Gross Profit
20.88M 15.19M 4.93M 6.4M 2.18M 2.04M -754K 231K 278K -945K -827K -784K -18.12M -15.46M -12.21M -10.63M -9.57M
Operating Income
-14.94M -11.49M -14.47M -16.26M -24.07M -16.9M -17.82M -23.05M -25.57M -31.14M -29.43M -29.25M -24.78M -24.21M -17.25M -15.78M -15.51M
Interest Income
437K 602K 1.02M 416K 503K 576K 723K 711K 642K 597K 458K 157K 35K 23K 26K 23K 9K
Pretax Income
-15.5M -11.81M -14.06M -16.45M -24.37M -17.2M -17.36M -22.53M -25.11M -23.9M -29.29M -29.41M -25.08M -20.75M -17.56M -16.09M -15.97M
Net Income
-15.59M -11.98M -14.08M -16.47M -24.42M -17.38M -17.4M -22.55M -25.14M -23.92M -29.31M -29.43M -25.1M -20.76M -17.58M -16.12M -16.01M
Selling & General & Admin
5.07M 4.02M 4.34M 5.18M 7.24M 5.44M 4.92M 5.6M 6.63M 6.45M 6.96M 9.32M 6.66M 5.75M 5.04M 5.15M 5.94M
Research & Development
30.74M 22.65M 15.07M 17.48M 19.01M 14.71M 15M 18.81M 19.62M 20.46M 22.47M 19.93M 18.2M 15.53M 12.41M 10.74M 10.07M
Other Expenses
n/a n/a n/a n/a n/a 3.38M -55K -1K -397K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
35.81M 26.68M 19.41M 22.66M 26.25M 23.52M 18.27M 24.41M 25.85M 26.91M 29.43M 29.25M 24.86M 21.28M 17.45M 15.89M 16.02M
Interest Expense
997K 924K 631K 610K 804K 874K 207K 188K 178K 317K 325K 323K 340K 343K 337K 334K 466K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
35.81M 26.68M 19.41M 22.66M 26.25M 23.52M 18.27M 24.41M 25.85M 26.91M 29.43M 29.25M 24.86M 21.28M 17.45M 15.89M 16.02M
Income Tax Expense
95K 176K 18K 21K 45K 174K 39K 19K 29K 16K 16K 15K 20K 18K 21K 30K 38K
Shares Outstanding (Basic)
227.92M 227.77M 2.27B 1.85B 1.69B 1.53B 1.52B 1.4B 135.21M 1.33B 1.27B 1.26B 1.26B 1.25B 1.24B 1.21B 1.15B
Shares Outstanding (Diluted)
227.92M 227.77M 2.27B 1.85B 1.69B 1.53B 1.52B 1.4B 135.21M 1.33B 1.27B 1.26B 1.26B 1.25B 1.24B 1.21B 1.15B
EPS (Basic)
-0.07 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.19 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01
EPS (Diluted)
-0.07 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.19 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01
EBITDA
-12.25M -8.65M -11.21M -13.62M -21.39M -15.13M -15.95M -21.22M -22.87M -22.62M -28.14M -28.31M -24.03M -19.68M -16.58M -15.2M -14.99M
EBIT
-14.5M -10.88M -13.43M -15.84M -23.57M -16.33M -17.15M -22.34M -24.93M -23.59M -28.97M -29.09M -24.74M -20.4M -17.23M -15.75M -15.5M
Depreciation & Amortization
2.25M 2.24M 2.22M 2.21M 2.18M 1.2M 1.2M 1.13M 2.06M 967K 827K 784K 708K 726K 644K 553K 508K